-
Behavioural scienceSmoking and vaping refines
E-cigarette flavour use and later vaping abstinence in US youth and adults, PATH 2016-2023
Exclusive tobacco or flavourless vaping preceded higher odds of 30-day e-cigarette abstinence, while use of multiple flavours preceded lower odds.
Peer-reviewed -
Health todayFrailty and multimorbidity new
Frailty at 50 linked to shorter healthy working life expectancy across 33 countries
In 180,314 adults from five harmonised ageing cohorts, healthy working life expectancy at age 50 was 11.87 years for robust participants, 7.34 years for pre-frail and 3.77 years for frail.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 confirms
GLP-1 receptor agonists do not improve cognition or function in Alzheimer's disease or MCI
GLP-1 receptor agonists improved neither cognition nor disease progression in pooled trials, with more adverse events and discontinuation.
Peer-reviewed -
Health todayCancer refines
Depression recorded after cancer diagnosis and suicide risk in 755,079 South Korean adults
Cancer patients with no prior depression who were later diagnosed with it had a suicide hazard 4.76 times that of those without.
Peer-reviewed -
Behavioural scienceInfection and pandemics refines
Bacteraemia resistance and strain trends in Calgary alongside antibiotic prescribing
Population-based Calgary cohort covering five bacteraemia pathogens, 2006 to 2022: fluoroquinolone resistance fell in Gram-positive species, while Escherichia coli ST1193 and CTX-M-27-producing ST131 rose.
Preprint · not peer-reviewed -
Data, models and systemsForecasts and their record new
US obesity treatment access modelled as 5.3 million preventable deaths over a decade
Modelling projects 5.3 million preventable deaths and $10.5-13.3 trillion foregone benefits over a decade of restricted obesity treatment access.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 new
GLP-1 agonists and atrial fibrillation in non-diabetic obesity with kidney disease
GLP-1 users with obesity and CKD had 1.63% one-year incident atrial fibrillation, against 2.62% in unexposed patients.
Peer-reviewed -
Behavioural scienceInfection and pandemics refines
Influenza antibody titres waned by strain, not uniformly, in Michigan and Hong Kong
H1N1 titres fell in Michigan and two H3N2 strains fell in Hong Kong; other strains changed little.
Preprint · not peer-reviewed -
Behavioural scienceDiet, exercise and sleep confirms
Moderate-to-vigorous activity and cardiovascular mortality in US adults with MASLD
Among 2785 adults with MASLD, 10 more minutes of moderate-to-vigorous activity gave a hazard ratio of 0.72 for cardiovascular death.
Peer-reviewed -
Data, models and systemsValue in health new
Enzalutamide in prostate cancer costs AUD$835,580 per QALY in ENZAMET trial analysis
Adding enzalutamide in the ENZAMET trial cost AUD$835,580 per QALY gained, far above the AUD$50,000 threshold.
Peer-reviewed -
Data, models and systemsWhat linked data reveals refines
Social needs Z59 codes and subsequent acute care across 21 US health systems
Emergency visits were 67% higher after a first Z59 hardship code, but an administrative code reproduced much of this.
Preprint · not peer-reviewed -
Health todayObesity, diabetes and GLP-1 new
Type 2 diabetes remission is uncommon, brief and usually ended by a treatment restart
Recorded remission reached 3.82% at five years in treated adults, and ended more often by treatment restart than rising HbA1c.
Preprint · not peer-reviewed
